Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lippia alba (Mill.) N.E.Br. ex Britton and P. Wilson is an aromatic medicinal plant native to Central and South America belonging to the Verbenaceae family. It has been traditionally used for a wide range of conditions including respiratory ailments (asthma, bronchitis, cough, cold), digestive issues (nausea, flatulence), cardiovascular problems (hypertension), nervous system disorders (anxiety, depression, insomnia), pain management, inflammation, fever, and infectious diseases (influenza, measles, malaria). The plant contains several bioactive compounds, notably essential oils with various chemotypes (including citral, carvone, limonene, linalool, myrcene), flavonoids, and polyphenols. Pharmacologically, Lippia alba exhibits sedative and anesthetic properties (particularly via the GABAergic pathway), inhibits acetylcholinesterase (AChE), reduces calcium influx, and demonstrates antioxidant, anti-inflammatory, antispasmodic, analgesic, antibacterial, antifungal, and antiviral activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lippia alba.